1. Home
  2. CREX vs KYNB Comparison

CREX vs KYNB Comparison

Compare CREX & KYNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Creative Realities Inc.

CREX

Creative Realities Inc.

SELL

Current Price

$2.24

Market Cap

35.7M

Sector

Technology

ML Signal

SELL

Logo Kyntra Bio Inc. Common Stock

KYNB

Kyntra Bio Inc. Common Stock

N/A

Current Price

$5.57

Market Cap

32.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CREX
KYNB
Founded
N/A
1993
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
35.7M
32.8M
IPO Year
2015
2014

Fundamental Metrics

Financial Performance
Metric
CREX
KYNB
Price
$2.24
$5.57
Analyst Decision
Strong Buy
Buy
Analyst Count
3
5
Target Price
$8.33
★ $38.50
AVG Volume (30 Days)
★ 29.9K
24.2K
Earning Date
11-11-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 9552.08
EPS
N/A
★ N/A
Revenue
★ $18,437,000.00
$6,440,000.00
Revenue This Year
$75.99
N/A
Revenue Next Year
$13.27
$14.12
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 5.61
N/A
52 Week Low
$2.26
$5.62
52 Week High
$4.42
$9.66

Technical Indicators

Market Signals
Indicator
CREX
KYNB
Relative Strength Index (RSI) 28.46 26.80
Support Level N/A $5.62
Resistance Level $2.59 $7.41
Average True Range (ATR) 0.10 0.34
MACD -0.01 -0.07
Stochastic Oscillator 18.76 1.33

Price Performance

Historical Comparison
CREX
KYNB

About CREX Creative Realities Inc.

Creative Realities Inc, along with its subsidiaries, is engaged in providing digital marketing technology & solutions to world-wide retail companies, luxury and other individual retail brands, advertising networks, outdoor clients, enterprises, and other organizations. The company operates in one reportable segment, marketing technology solutions. It offers solutions related to digital merchandising systems, omnichannel customer engagement systems, interactive digital shopping assistants, advisors and kiosks, and high-end audio-visual networks, along with marketing technologies such as mobile, social media, point-of-sale transactions, beaconing, and web-based media. Geographically, the company generates maximum revenue from the United States, and the rest from Canada.

About KYNB Kyntra Bio Inc. Common Stock

Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.

Share on Social Networks: